SYN logo

Synthetic Biologics (SYN) Total Assets

Annual Total Assets

$70.36 M
+$61.95 M+736.68%

December 31, 2021

Summary

Performance

1-Year Change

+736.68%

3-Year Change

+133.45%

5-Year Change

+273.53%

15-Year Change

+273.53%

SYN Total Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$70.36 M
SYN annual total assets is currently at an all-time high

3-Year Low

$70.36 M
SYN annual total assets is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2021
SYN previous annual earnings announcement was published on Dec 31, 2021

Next Annual Earnings Report Date

N/A
SYN next annual earnings announcement has not yet been scheduled

OtherSYNbalance sheetmetrics:

Annual Current Assets

$68.86 M
SYN annual total current assets is $68.86 million

Annual Non Current Assets

$1.51 M
SYN annual long term assets is $1.51 million

Annual Total Liabilities

$4.96 M
SYN annual total liabilities is $4.96 million

Annual Current Liabilities

$3.55 M
SYN annual total current liabilities is $3.55 million

Quarterly Total Assets

$82.33 M
-$6.67 M-7.49%

June 30, 2022

Summary

Performance

3-Month Change

-7.49%

1-Year Change

+6.57%

3-Year Change

+243.06%

5-Year Change

+423.07%

SYN Quarterly Total Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$89.00 M
SYN quarterly total assets is currently -7.49% below its historical high of $89.00 million

3-Year Low

$70.36 M
SYN quarterly total assets is currently +17.01% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2022
SYN previous earnings announcement was published on Jun 30, 2022

Next Quarterly Earnings Report Date

N/A
SYN next earnings announcement has not yet been scheduled

OtherSYNbalance sheetmetrics:

Quarterly Current Assets

$54.89 M
SYN quarterly total current assets is $54.89 million

Quarterly Non Current Assets

$27.44 M
SYN quarterly long term assets is $27.44 million

Quarterly Total Liabilities

$20.66 M
SYN quarterly total liabilities is $20.66 million

Quarterly Current Liabilities

$13.26 M
SYN quarterly total current liabilities is $13.26 million

Total Assets Formula

Total Assets = Current Assets + Non-Current Assets

Annual Total Assets

$70.36 M
SYN annual total assets is $70.36 million

Annual Non Current Assets

$1.51 M
SYN annual long term assets is $1.51 million

Annual Current Assets

$68.86 M
SYN annual total current assets is $68.86 million

SYN Total Assets Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+736.7%+6.6%
3 y3 years+133.4%+243.1%
5 y5 years+273.5%+423.1%

SYN Total Assets Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat highat low-7.5%-14.5%
5 y5-yearat high-88.0%-7.5%-91.3%
alltimeall timeat high-99.4%-7.5%-100.0%

Synthetic Biologics Total Assets History

DateAnnualQuarterly
Jun 2022
-
$82.33 M(-7.5%)
Mar 2022
-
$89.00 M(+26.5%)
Dec 2021
$70.36 M(+736.7%)
$70.36 M(-6.3%)
Sep 2021
-
$75.12 M(-2.8%)
Jun 2021
-
$77.25 M(-2.3%)
Mar 2021
-
$79.05 M(+840.0%)
Dec 2020
$8.41 M(-51.2%)
$8.41 M(+16.8%)
Sep 2020
-
$7.20 M(-24.8%)
Jun 2020
-
$9.58 M(-19.4%)
Mar 2020
-
$11.89 M(-31.0%)
Dec 2019
$17.23 M(-42.8%)
$17.23 M(-16.9%)
Sep 2019
-
$20.74 M(-13.6%)
Jun 2019
-
$24.00 M(-9.9%)
Mar 2019
-
$26.63 M(-11.6%)
Dec 2018
$30.14 M(+60.0%)
$30.14 M(+179.2%)
Sep 2018
-
$10.80 M(+28.2%)
Jun 2018
-
$8.42 M(-32.5%)
Mar 2018
-
$12.47 M(-33.8%)
Dec 2017
$18.84 M(-16.3%)
$18.84 M(-19.1%)
Sep 2017
-
$23.28 M(+47.9%)
Jun 2017
-
$15.74 M(-11.2%)
Mar 2017
-
$17.72 M(-21.2%)
Dec 2016
$22.50 M(-27.1%)
$22.50 M(+172.8%)
Sep 2016
-
$8.25 M(-49.5%)
Jun 2016
-
$16.33 M(-28.2%)
Mar 2016
-
$22.74 M(-26.3%)
Dec 2015
$30.84 M(+61.1%)
$30.84 M(-27.7%)
Sep 2015
-
$42.63 M(+260.2%)
Jun 2015
-
$11.84 M(-13.7%)
Mar 2015
-
$13.72 M(-28.4%)
Dec 2014
$19.14 M(+17.8%)
$19.14 M(+303.8%)
Sep 2014
-
$4.74 M(-49.0%)
Jun 2014
-
$9.29 M(-25.9%)
Mar 2014
-
$12.53 M(-22.9%)
Dec 2013
$16.26 M(+21.1%)
$16.26 M(+133.8%)
Sep 2013
-
$6.95 M(-27.8%)
Jun 2013
-
$9.63 M(-17.6%)
Mar 2013
-
$11.68 M(-13.0%)
Dec 2012
$13.42 M(+79.5%)
$13.42 M(+130.4%)
Sep 2012
-
$5.83 M(-19.6%)
Jun 2012
-
$7.25 M(-13.2%)
Mar 2012
-
$8.35 M(+11.7%)
Dec 2011
$7.48 M(+81.9%)
$7.48 M(-13.8%)
Sep 2011
-
$8.68 M(-8.9%)
Jun 2011
-
$9.52 M(+32.1%)
Mar 2011
-
$7.21 M(+75.3%)
Dec 2010
$4.11 M(+0.9%)
$4.11 M(-12.2%)
Sep 2010
-
$4.68 M(+3.4%)
Jun 2010
-
$4.53 M(+38.3%)
Mar 2010
-
$3.27 M(-19.7%)
Dec 2009
$4.08 M
$4.08 M(-19.7%)
Sep 2009
-
$5.08 M(-11.5%)
DateAnnualQuarterly
Jun 2009
-
$5.73 M(-14.4%)
Mar 2009
-
$6.70 M(-9.3%)
Dec 2008
$7.39 M(-45.8%)
$7.39 M(-10.0%)
Sep 2008
-
$8.21 M(-12.8%)
Jun 2008
-
$9.41 M(-13.2%)
Mar 2008
-
$10.84 M(-20.5%)
Dec 2007
$13.63 M(+8.9%)
$13.63 M(+46.3%)
Sep 2007
-
$9.32 M(-12.8%)
Jun 2007
-
$10.69 M(-7.8%)
Mar 2007
-
$11.59 M(-7.4%)
Dec 2006
$12.52 M(+769.2%)
$12.52 M(>+9900.0%)
Sep 2006
-
$0.00(0.0%)
Jun 2006
-
$0.00(0.0%)
Mar 2006
-
$0.00(-100.0%)
Dec 2005
$1.44 M(-4.9%)
-
Mar 2003
-
$1.24 M(-17.9%)
Dec 2002
$1.51 M(-26.3%)
$1.51 M(-15.4%)
Sep 2002
-
$1.79 M(-21.8%)
Jun 2002
-
$2.29 M(-1.5%)
Mar 2002
-
$2.33 M(+13.1%)
Dec 2001
$2.06 M(-62.3%)
$2.06 M(-36.6%)
Sep 2001
-
$3.24 M(-7.4%)
Jun 2001
-
$3.50 M(-2.9%)
Mar 2001
-
$3.61 M(-33.8%)
Dec 2000
$5.45 M(+8.0%)
$5.45 M(+57.2%)
Sep 2000
-
$3.47 M(-12.0%)
Jun 2000
-
$3.94 M(-38.1%)
Mar 2000
-
$6.36 M(+26.0%)
Dec 1999
$5.05 M(+76.4%)
$5.05 M(+215.5%)
Sep 1999
-
$1.60 M(-11.1%)
Jun 1999
-
$1.80 M(-21.7%)
Mar 1999
-
$2.30 M(-19.7%)
Dec 1998
$2.86 M(+308.9%)
$2.86 M(-7.7%)
Sep 1998
-
$3.10 M(-48.3%)
Jun 1998
-
$6.00 M(+2900.0%)
Mar 1998
-
$200.00 K(-71.4%)
Dec 1997
$700.00 K(-75.0%)
$700.00 K(-46.2%)
Sep 1997
-
$1.30 M(+18.2%)
Jun 1997
-
$1.10 M(-68.6%)
Mar 1997
-
$3.50 M(+25.0%)
Dec 1996
$2.80 M(+27.3%)
$2.80 M(-39.1%)
Sep 1996
-
$4.60 M(-19.3%)
Jun 1996
-
$5.70 M(+128.0%)
Mar 1996
-
$2.50 M(+13.6%)
Dec 1995
$2.20 M(+450.0%)
$2.20 M(-33.3%)
Sep 1995
-
$3.30 M(+725.0%)
Dec 1994
$400.00 K(-77.8%)
$400.00 K(-91.5%)
Mar 1994
-
$4.70 M(+161.1%)
Dec 1993
$1.80 M
$1.80 M(-37.9%)
Sep 1993
-
$2.90 M(-34.1%)
Jun 1993
-
$4.40 M(-12.0%)
Mar 1993
-
$5.00 M

FAQ

  • What is Synthetic Biologics annual total assets?
  • What is the all time high annual total assets for Synthetic Biologics?
  • What is Synthetic Biologics annual total assets year-on-year change?
  • What is Synthetic Biologics quarterly total assets?
  • What is the all time high quarterly total assets for Synthetic Biologics?
  • What is Synthetic Biologics quarterly total assets year-on-year change?

What is Synthetic Biologics annual total assets?

The current annual total assets of SYN is $70.36 M

What is the all time high annual total assets for Synthetic Biologics?

Synthetic Biologics all-time high annual total assets is $70.36 M

What is Synthetic Biologics annual total assets year-on-year change?

Over the past year, SYN annual total assets has changed by +$61.95 M (+736.68%)

What is Synthetic Biologics quarterly total assets?

The current quarterly total assets of SYN is $82.33 M

What is the all time high quarterly total assets for Synthetic Biologics?

Synthetic Biologics all-time high quarterly total assets is $89.00 M

What is Synthetic Biologics quarterly total assets year-on-year change?

Over the past year, SYN quarterly total assets has changed by +$5.08 M (+6.57%)